
The Transparent PBM Shift: What It Means for Your Clients
The Big 3 are reinventing themselves. New transparent models from Express Scripts, CVS, and Optum Rx are reshaping how rebates flow, how pricing works, and how plans perform. But transparency doesn’t guarantee lower costs. For some of your clients, these models open the door to real savings. For others, they create new risks.
In this moderated panel discussion built for benefits advisors representing self-insured plans, learn how to cut through the noise and you guide each client to the right decision.
Presented By
Kyra Hagan | Moderator SVP/Marketing and Communications
Nathan White Chief Client Officer
Mark Campbell, PharmD Chief Pharmacy Officer
What You’ll Learn:
- Why utilization modeling, not the lowest visible price, should shape your PBM recommendations
- Which therapeutic categories signal whether a client is advantaged or disadvantaged under a transparent model
- What’s changing with rebates and why PMPM guarantees matter more than rates
- Where ESI Signature, the CVS models, Optum Rx, and Illuminate Rx stand today